Share Price and Basic Stock Data

Last Updated: November 14, 2024, 6:26 pm

Market Cap	1,454 Cr.
Current Price	1,694
High / Low	1,910/660
Stock P/E	33.8
Book Value	287
Dividend Yield	0.18 %
ROCE	21.0 %
ROE	15.4 %
Face Value	10.0
PEG Ratio	-1.54

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for 3B Blackbio DX Ltd

Competitors of 3B Blackbio DX Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Epigral Ltd	8,673 Cr.	2,010	2,408/886	29.6	337	0.25 %	17.5 %	16.9 %	10.0
Dharmaj Crop Guard Ltd	957 Cr.	283	390/197	23.7	117	0.00 %	14.5 %	13.2 %	10.0
Bhaskar Agrochemicals Ltd	34.1 Cr.	65.5	122/42.1	17.3	29.2	0.00 %	14.7 %	13.4 %	10.0
Bhagiradha Chemicals & Industries Ltd	4,094 Cr.	328	448/117	152	51.0	0.03 %	9.69 %	6.27 %	1.00
Best Agrolife Ltd	1,430 Cr.	606	918/454	38.8	320	0.49 %	16.5 %	18.1 %	10.0
Industry Average	12,393.00 Cr	1,809.91		47.11	375.95	0.30%	13.80%	15.51%	7.35

All Competitor Stocks of 3B Blackbio DX Ltd

Quarterly Result

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	33	15	14	18	12	17	15	18	14	19	18	23	19
Expenses	14	9	7	12	7	8	7	11	8	11	9	13	8
Operating Profit	18	6	7	6	5	9	7	7	6	8	9	10	11
OPM %	56%	39%	49%	32%	44%	53%	50%	41%	45%	41%	50%	43%	56%
Other Income	2	2	2	2	1	2	3	1	3	3	3	4	4
Interest	0	0	0	-0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before tax	20	8	8	8	6	11	10	8	9	10	11	14	14
Tax %	24%	24%	21%	37%	24%	23%	22%	38%	22%	26%	24%	36%	21%
Net Profit	15	6	7	5	5	8	8	5	7	8	9	9	11
EPS in Rs	17.53	6.85	7.66	5.53	5.39	11.20	8.96	7.72	9.71	10.46	10.16	10.33	12.97

Last Updated: October 7, 2024, 8:49 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: September 23, 2024, 3:12 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	20	22	19	17	16	23	23	29	227	81	62	74	79
Expenses	19	21	18	16	14	18	16	20	77	44	33	41	42
Operating Profit	1	1	1	2	3	5	7	9	150	37	29	33	37
OPM %	6%	6%	7%	9%	16%	23%	31%	32%	66%	46%	47%	44%	47%
Other Income	0	0	0	0	0	0	1	2	3	7	7	13	13
Interest	1	1	1	1	1	1	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	1	1	1	1	1	1	1
Profit before tax	1	0	0	0	1	5	7	10	152	43	35	44	50
Tax %	34%	14%	23%	23%	19%	24%	25%	23%	25%	26%	27%	28%
Net Profit	0	0	0	0	1	3	5	8	114	32	26	32	36
EPS in Rs	0.62	0.59	0.36	0.51	1.76	5.35	8.18	10.24	151.66	42.89	34.55	37.40	43.92
Dividend Payout %	0%	0%	0%	0%	17%	9%	6%	7%	6%	24%	8%	8%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	200.00%	66.67%	60.00%	1325.00%	-71.93%	-18.75%	23.08%
Change in YoY Net Profit Growth (%)	0.00%	-133.33%	-6.67%	1265.00%	-1396.93%	53.18%	41.83%

3B Blackbio DX Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	13%
5 Years:	26%
3 Years:	-31%
TTM:	35%

Compounded Profit Growth
10 Years:	56%
5 Years:	44%
3 Years:	-34%
TTM:	61%

Stock Price CAGR
10 Years:	69%
5 Years:	81%
3 Years:	58%
1 Year:	135%

Return on Equity
10 Years:	32%
5 Years:	33%
3 Years:	17%
Last Year:	15%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 6:31 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	6	6	6	6	6	6	6	7	7	7	9	9	9
Reserves	3	4	4	4	5	12	16	25	125	146	185	214	238
Borrowings	6	7	8	8	9	6	6	4	2	3	2	1	1
Other Liabilities	7	7	7	6	6	6	8	9	59	37	19	24	22
Total Liabilities	23	24	25	24	26	30	36	45	194	192	214	248	269
Fixed Assets	4	4	4	3	3	4	4	4	5	7	8	7	7
CWIP	-0	-0	-0	-0	0	0	0	0	0	0	0	-0	-0
Investments	-0	-0	-0	-0	-0	-0	-0	1	59	93	92	117	133
Other Assets	19	20	21	21	22	26	32	40	130	93	114	123	129
Total Assets	23	24	25	24	26	30	36	45	194	192	214	248	269

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-1	0	0	1	1	2	4	7	98	37	20	27
Cash from Investing Activity +	0	-0	-0	-0	-0	-1	-1	-1	-70	-28	15	-20
Cash from Financing Activity +	-0	0	-0	-1	-0	0	-1	1	-2	-15	-5	-4
Net Cash Flow	-1	0	-0	0	0	1	2	7	26	-6	30	3

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-5.00	-6.00	-7.00	-6.00	-6.00	-1.00	1.00	5.00	148.00	34.00	27.00	32.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	220	213	262	283	321	259	290	252	56	136	200	179
Inventory Days	149	120	145	143	175						164	141
Days Payable	220	189	218	203	186						69	66
Cash Conversion Cycle	149	144	188	223	310	259	290	252	56	136	296	253
Working Capital Days	214	218	274	312	377	308	351	302	67	169	248	216
ROCE %	8%	7%	7%	7%	13%	24%	28%	31%	162%	27%	19%	21%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoters	38.35%	38.35%	38.43%	38.43%	38.43%	38.43%	38.43%	38.43%	38.43%	38.43%	38.43%	41.29%
FIIs	1.47%	0.54%	1.23%	1.64%	1.64%	1.64%	2.11%	2.54%	3.06%	3.16%	3.38%	2.97%
DIIs	0.09%	0.08%	0.08%	0.08%	0.08%	0.00%	0.00%	0.00%	0.00%	0.82%	1.18%	1.89%
Public	60.09%	61.03%	60.26%	59.85%	59.85%	59.94%	59.47%	59.02%	58.50%	57.60%	56.99%	53.85%
No. of Shareholders	10,541	16,251	16,756	16,468	16,316	15,415	13,798	13,136	12,416	10,513	10,088	9,753

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	37.46	34.55	43.40	151.66	10.25
Diluted EPS (Rs.)	37.46	34.55	43.40	151.66	10.25
Cash EPS (Rs.)	38.70	35.77	43.88	152.82	10.98
Book Value[Excl.RevalReserv]/Share (Rs.)	263.15	261.50	229.69	197.92	45.73
Book Value[Incl.RevalReserv]/Share (Rs.)	263.15	261.50	229.69	197.92	45.73
Revenue From Operations / Share (Rs.)	86.51	82.54	107.65	302.66	38.54
PBDIT / Share (Rs.)	53.12	48.55	58.73	204.07	14.57
PBIT / Share (Rs.)	51.88	47.40	57.84	203.25	13.86
PBT / Share (Rs.)	51.74	47.13	57.69	202.94	13.42
Net Profit / Share (Rs.)	37.46	34.62	42.98	152.00	10.26
NP After MI And SOA / Share (Rs.)	38.20	34.62	42.98	152.00	10.26
PBDIT Margin (%)	61.40	58.81	54.56	67.42	37.80
PBIT Margin (%)	59.97	57.42	53.72	67.15	35.95
PBT Margin (%)	59.80	57.10	53.59	67.05	34.81
Net Profit Margin (%)	43.30	41.94	39.92	50.21	26.62
NP After MI And SOA Margin (%)	44.16	41.94	39.92	50.21	26.62
Return on Networth / Equity (%)	14.67	15.14	21.04	86.23	23.93
Return on Capital Employeed (%)	19.28	17.76	24.73	101.13	28.30
Return On Assets (%)	13.19	12.11	16.76	58.83	17.14
Long Term Debt / Equity (X)	0.00	0.01	0.01	0.01	0.04
Total Debt / Equity (X)	0.00	0.01	0.01	0.01	0.10
Asset Turnover Ratio (%)	0.32	0.30	0.13	0.38	0.41
Current Ratio (X)	7.04	8.05	4.82	2.76	4.82
Quick Ratio (X)	6.56	7.49	4.38	2.64	4.32
Inventory Turnover Ratio (X)	2.41	2.33	2.66	2.68	2.48
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	20.17
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	18.85
Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	79.83
Cash Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	81.15
Interest Coverage Ratio (X)	365.87	183.32	413.58	669.53	32.67
Interest Coverage Ratio (Post Tax) (X)	259.05	131.73	303.65	499.68	23.99
Enterprise Value (Cr.)	600.55	278.94	248.35	196.43	50.63
EV / Net Operating Revenue (X)	8.10	4.51	3.08	0.86	1.75
EV / EBITDA (X)	13.19	7.67	5.64	1.28	4.64
MarketCap / Net Operating Revenue (X)	8.90	5.04	3.17	0.94	1.88
Retention Ratios (%)	0.00	0.00	0.00	0.00	79.82
Price / BV (X)	2.96	1.82	1.67	1.62	1.69
Price / Net Operating Revenue (X)	8.90	5.04	3.17	0.94	1.88
EarningsYield	0.04	0.08	0.12	0.53	0.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of 3B Blackbio DX Ltd as of November 14, 2024 is: 1,496.58

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 14, 2024, 3B Blackbio DX Ltd is Overvalued by 11.65% compared to the current share price 1,694.00

Intrinsic Value of 3B Blackbio DX Ltd as of November 14, 2024 is: 1,168.04

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 14, 2024, 3B Blackbio DX Ltd is Overvalued by 31.05% compared to the current share price 1,694.00

Last 5 Year EPS CAGR: -21.95%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 29.50%, which is a positive sign. The company has higher reserves (75.46 cr) compared to borrowings (4.85 cr), indicating strong financial stability. The company has shown consistent growth in sales (53.23 cr) and profit (26.77 cr) over the years.	The stock has a high average Working Capital Days of 254.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 213.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 3B Blackbio DX Ltd:
1. Net Profit Margin: 43.3%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 19.28% (Industry Average ROCE: 13.8%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.67% (Industry Average ROE: 15.51%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 259.05
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 6.56
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 33.8 (Industry average Stock P/E: 34.82)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Kilpest India Ltd. is a Public Limited Listed company incorporated on 27/05/1972 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24211MP1972PLC001131 and registration number is 001131. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company’s Total Operating Revenue is Rs. 15.52 Cr. and Equity Capital is Rs. 7.49 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Agro Chemicals/Pesticides	7-C, Industrial Area, Govindpura, Bhopal Madhya Pradesh 462023	info@kilpest.com http://www.kilpest.com

Management
Name	Position Held
Mr. Dhirendra Dubey	Chairman & Managing Director
Mr. N K Dubey	Whole Time Director
CA. Shabbar Husain	Independent Director
Mr. Abdul Moin Khan	Independent Director
Mrs. Mithala Dubey	Director
Mr. Harihar Prasad Thapak	Independent Director

FAQ

What is the latest intrinsic value of 3B Blackbio DX Ltd?

The latest intrinsic value of 3B Blackbio DX Ltd as on 14 November 2024 is ₹1496.58, which is 11.65% lower than the current market price of ₹1,694.00.

What is the Market Cap of 3B Blackbio DX Ltd?

The Market Cap of 3B Blackbio DX Ltd is 1,454 Cr..

What is the current Stock Price of 3B Blackbio DX Ltd as on 14 November 2024?

The current stock price of 3B Blackbio DX Ltd as on 14 November 2024 is ₹1,694.

What is the High / Low of 3B Blackbio DX Ltd stocks in FY 2024?

In FY 2024, the High / Low of 3B Blackbio DX Ltd stocks is 1,910/660.

What is the Stock P/E of 3B Blackbio DX Ltd?

The Stock P/E of 3B Blackbio DX Ltd is 33.8.

What is the Book Value of 3B Blackbio DX Ltd?

The Book Value of 3B Blackbio DX Ltd is 287.

What is the Dividend Yield of 3B Blackbio DX Ltd?

The Dividend Yield of 3B Blackbio DX Ltd is 0.18 %.

What is the ROCE of 3B Blackbio DX Ltd?

The ROCE of 3B Blackbio DX Ltd is 21.0 %.

What is the ROE of 3B Blackbio DX Ltd?

The ROE of 3B Blackbio DX Ltd is 15.4 %.

What is the Face Value of 3B Blackbio DX Ltd?

The Face Value of 3B Blackbio DX Ltd is 10.0.